Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Operating Income 2010-2025 | MKKGY

Merck annual/quarterly operating income history and growth rate from 2010 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Merck operating income for the quarter ending March 31, 2025 was $1.061B, a 4.96% increase year-over-year.
  • Merck operating income for the twelve months ending March 31, 2025 was $3.995B, a 4.95% increase year-over-year.
  • Merck annual operating income for 2024 was $3.945B, a 0.98% increase from 2023.
  • Merck annual operating income for 2023 was $3.907B, a 17.11% decline from 2022.
  • Merck annual operating income for 2022 was $4.714B, a 4.64% decline from 2021.
  
Merck Annual Operating Income
(Millions of US $)
2024 $3,945
2023 $3,907
2022 $4,714
2021 $4,943
2020 $3,410
2019 $2,374
2018 $2,038
2017 $2,854
2016 $2,747
2015 $2,045
2014 $2,342
2013 $2,893
2012 $1,984
2011 $1,555
2010 $12,338
2009 $10,807
Merck Quarterly Operating Income
(Millions of US $)
2025-03-31 $1,061
2024-12-31 $874
2024-09-30 $1,206
2024-06-30 $854
2024-03-31 $1,011
2023-12-31 $667
2023-09-30 $1,071
2023-06-30 $1,058
2023-03-31 $1,111
2022-12-31 $904
2022-09-30 $1,244
2022-06-30 $1,249
2022-03-31 $1,316
2021-12-31 $1,186
2021-09-30 $1,236
2021-06-30 $1,264
2021-03-31 $1,257
2020-12-31 $716
2020-09-30 $1,363
2020-06-30 $541
2020-03-31 $790
2019-12-31 $572
2019-09-30 $678
2019-06-30 $695
2019-03-31 $429
2018-12-31 $361
2018-09-30 $571
2018-06-30 $469
2018-03-31 $638
2017-12-31 $301
2017-09-30 $1,058
2017-06-30 $691
2017-03-31 $805
2016-12-31 $433
2016-09-30 $754
2016-06-30 $622
2016-03-31 $937
2015-12-31 $329
2015-09-30 $644
2015-06-30 $554
2015-03-31 $573
2014-12-31 $112
2014-09-30 $569
2014-06-30 $504
2014-03-31 $644
2013-12-31 $539
2013-09-30 $830
2013-06-30 $870
2013-03-31 $643
2012-12-31 $3,646
2012-09-30 $601
2012-06-30 $79
2012-03-31 $3,274
2011-12-31 $3,311
2011-09-30 $3,585
2011-06-30 $151
2011-03-31 $3,505
2010-12-31 $3,707
2010-09-30 $618
2010-06-30 $2,695
2010-03-31 $2,791
2009-12-31 $2,983
2009-09-30 $2,778
2009-06-30 $2,590
2009-03-31 $2,456
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $16.394B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $84.744B 31.79
Zoetis (ZTS) United States $70.049B 26.14
Takeda Pharmaceutical (TAK) Japan $46.838B 9.32
Daiichi Sankyo, - (DSNKY) Japan $43.381B 22.23
BeOne Medicines - (ONC) Cayman Islands $28.223B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.505B 0.00
Summit Therapeutics (SMMT) United States $15.143B 0.00
Shionogi (SGIOY) Japan $14.700B 14.73
United Therapeutics (UTHR) United States $12.918B 11.43
Neurocrine Biosciences (NBIX) United States $12.450B 42.64
Orion OYJ (ORINY) Finland $10.594B 28.65
IPSEN (IPSEY) France $9.607B 0.00
Corcept Therapeutics (CORT) United States $7.877B 64.03
Stevanato Group S.p.A (STVN) Italy $7.099B 43.41
Madrigal Pharmaceuticals (MDGL) United States $6.283B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ionis Pharmaceuticals (IONS) United States $5.996B 0.00
Grifols, S.A (GRFS) Spain $5.755B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $4.103B 0.00
Hypermarcas (HYPMY) Brazil $2.907B 19.12
Crinetics Pharmaceuticals (CRNX) United States $2.800B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.698B 9.45
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.481B 13.41
BioCryst Pharmaceuticals (BCRX) United States $2.074B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.044B 0.00
Indivior (INDV) United States $1.923B 8.16
Centessa Pharmaceuticals (CNTA) United Kingdom $1.736B 0.00
ARS Pharmaceuticals (SPRY) United States $1.627B 0.00
Endo (NDOI) United States $1.595B 0.00
Evotec AG (EVO) Germany $1.353B 0.00
Ocular Therapeutix (OCUL) United States $1.333B 0.00
Guardian Pharmacy Services (GRDN) United States $1.286B 0.00
Dyne Therapeutics (DYN) United States $1.155B 0.00
Harrow (HROW) United States $1.137B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.058B 21.16
Enliven Therapeutics (ELVN) United States $0.996B 0.00
Verve Therapeutics (VERV) United States $0.990B 0.00
Collegium Pharmaceutical (COLL) United States $0.960B 5.18
Akebia Therapeutics (AKBA) United States $0.956B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.923B 0.00
Ardelyx (ARDX) United States $0.869B 0.00
Elite Pharmaceuticals (ELTP) United States $0.801B 0.00
Xeris Biopharma Holdings (XERS) United States $0.726B 0.00
Cronos Group (CRON) Canada $0.721B 0.00
Xencor (XNCR) United States $0.599B 0.00
KalVista Pharmaceuticals (KALV) United States $0.593B 0.00
Altimmune (ALT) United States $0.567B 0.00
USANA Health Sciences (USNA) United States $0.565B 12.29
Regulus Therapeutics (RGLS) United States $0.564B 0.00
Relay Therapeutics (RLAY) United States $0.554B 0.00
Bioventus (BVS) United States $0.536B 13.58
Theravance Biopharma (TBPH) United States $0.529B 0.00
Liminatus Pharma (LIMN) United States $0.520B 0.00
AleAnna (ANNA) United States $0.504B 0.00
Zevra Therapeutics (ZVRA) United States $0.492B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.447B 0.00
Siga Technologies (SIGA) United States $0.442B 9.24
Tourmaline Bio (TRML) United States $0.437B 0.00
Organogenesis (ORGO) United States $0.424B 0.00
Oruka Therapeutics (ORKA) United States $0.408B 0.00
Savara (SVRA) United States $0.373B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.337B 9.10
Aquestive Therapeutics (AQST) United States $0.327B 0.00
Heron Therapeutics (HRTX) United States $0.322B 0.00
Nature's Sunshine Products (NATR) United States $0.275B 25.27
Tonix Pharmaceuticals Holding (TNXP) United States $0.241B 0.00
Nanobiotix S.A (NBTX) France $0.208B 0.00
Esperion Therapeutics (ESPR) United States $0.206B 0.00
MediWound (MDWD) Israel $0.205B 0.00
OmniAb (OABI) United States $0.197B 0.00
Aldeyra Therapeutics (ALDX) United States $0.185B 0.00
Profound Medical (PROF) Canada $0.181B 0.00
ProKidney (PROK) United States $0.177B 0.00
4D Molecular Therapeutics (FDMT) United States $0.175B 0.00
Galectin Therapeutics (GALT) United States $0.157B 0.00
Larimar Therapeutics (LRMR) United States $0.155B 0.00
Aclaris Therapeutics (ACRS) United States $0.151B 0.00
Journey Medical (DERM) United States $0.149B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Avita Medical (RCEL) United States $0.136B 0.00
Achieve Life Sciences (ACHV) Canada $0.133B 0.00
Lyell Immunopharma (LYEL) United States $0.133B 0.00
Lexeo Therapeutics (LXEO) United States $0.131B 0.00
VAXART, INC (VXRT) United States $0.128B 0.00
Inhibikase Therapeutics (IKT) United States $0.123B 0.00
Nektar Therapeutics (NKTR) United States $0.118B 0.00
Champions Oncology (CSBR) United States $0.111B 18.32
Protara Therapeutics (TARA) United States $0.111B 0.00
Korro Bio (KRRO) United States $0.110B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.109B 0.00
Cardiol Therapeutics (CRDL) Canada $0.106B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.097B 0.00
Cassava Sciences (SAVA) United States $0.091B 0.00
Unicycive Therapeutics (UNCY) United States $0.090B 0.00
Nutriband (NTRB) United States $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Dominari Holdings (DOMH) United States $0.080B 0.00
Fractyl Health (GUTS) United States $0.079B 0.00
Surrozen (SRZN) United States $0.077B 0.00
Wellgistics Health (WGRX) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Pyxis Oncology (PYXS) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Assertio Holdings (ASRT) United States $0.060B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.059B 43.67
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Rafael Holdings (RFL) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.056B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
NRx Pharmaceuticals (NRXP) United States $0.054B 0.00
Metagenomi (MGX) United States $0.053B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Context Therapeutics (CNTX) United States $0.051B 0.00
Telomir Pharmaceuticals (TELO) United States $0.050B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Jupiter Neurosciences (JUNS) United States $0.040B 0.00
Klotho Neurosciences (KLTO) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.032B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
FibroGen (FGEN) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
Ernexa Therapeutics (ERNA) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
BioLineRx (BLRX) Israel $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
Lyra Therapeutics (LYRA) United States $0.015B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.16
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Citius Pharmaceuticals (CTXR) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Talphera (TLPH) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Plus Therapeutics (PSTV) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
GlycoMimetics (CBIO) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00